The verification dataset results showed that the expression levels of DCAF12 and HSPA1A in MG samples were significantly decreased compared to those in the normal sample, which was consistent with their expression trends in the GSE85452 dataset (Figure 6(a)). The gene discussed is HSPA1A; the disease is myasthenia gravis.